Search by Drug Name or NDC

    NDC 00006-5369-03 SEGLUROMET 2.5; 500 mg/1; mg/1 Details

    SEGLUROMET 2.5; 500 mg/1; mg/1

    SEGLUROMET is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Merck Sharp & Dohme LLC. The primary component is ERTUGLIFLOZIN PIDOLATE; METFORMIN HYDROCHLORIDE.

    Product Information

    NDC 00006-5369
    Product ID 0006-5369_1712582f-570b-4357-b604-8ebb154b33d6
    Associated GPIs 27996002450310
    GCN Sequence Number 078051
    GCN Sequence Number Description ertugliflozin/metformin TABLET 2.5-500 MG ORAL
    HIC3 C4E
    HIC3 Description ANTIHYPERGLYCEMIC-SGLT2 INHIBITOR-BIGUANIDE COMBS.
    GCN 44284
    HICL Sequence Number 044716
    HICL Sequence Number Description ERTUGLIFLOZIN PIDOLATE/METFORMIN HCL
    Brand/Generic Brand
    Proprietary Name SEGLUROMET
    Proprietary Name Suffix n/a
    Non-Proprietary Name ertugliflozin and metformin hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 2.5; 500
    Active Ingredient Units mg/1; mg/1
    Substance Name ERTUGLIFLOZIN PIDOLATE; METFORMIN HYDROCHLORIDE
    Labeler Name Merck Sharp & Dohme LLC
    Pharmaceutical Class Biguanide [EPC], Biguanides [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA209806
    Listing Certified Through 2024-12-31

    Package

    NDC 00006-5369-03 (00006536903)

    NDC Package Code 0006-5369-03
    Billing NDC 00006536903
    Package 60 TABLET, FILM COATED in 1 BOTTLE (0006-5369-03)
    Marketing Start Date 2017-12-19
    NDC Exclude Flag N
    Pricing Information N/A